Trump's drug price announcement was a rushed publicity stunt that actually delivered worse deals than existing agreements. He quietly released the results at 6 p.m., without press events, and hid that negotiated prices were higher than the voluntary deals already secured. Medicare beneficiaries were shortchanged by $276 for Ozempic, compared to the $245 price already available. These negotiated prices are designed to avoid attention.

There'sGovernment aprice-setting 30%policies chancerisk thatundermining the engine of medical innovation. Even a modest reduction in expected U.S. federalrevenues governmentcan willprompt passcompanies legislationto bypare 2040back toresearch provideand universaldevelopment. healthcareThe consequence is stark: Breakthroughs for Americanchronic citizens,diseases accordingor novel cancers may be delayed or abandoned because firms no longer see sufficient return on investment to thejustify Metaculuscostly, predictionhigh-risk communitydevelopment — trading tomorrow’s cures for today’s savings.